Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
92.730
+0.060
+0.06%
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
⚠ Selloff or Market Correction? Either Way, Here's What to Do Next
See Overvalued Stocks
Ubs (lux) Investment Sicav - China A Opportunity (usd) I-a2-acc Usd (0P0001EGG6)
Add to/Remove from a Portfolio
Add to Watchlist
20/12 - Delayed Data. Currency in USD
- Morningstar Rating:
- Total Assets: 1.18B
Type:
Fund
Market:
Luxembourg
Issuer:
UBS Fund Management (Luxembourg) S.A.
ISIN:
LU1675058645
Asset Class:
Equity
UBS (Lux) Investment SICAV - China A Opportunity (
92.730
+0.060
+0.06%
- General
- Chart
- News & Analysis
- Technical
- Forum
- Overview
- Profile
- Historical Data
- Holdings
0P0001EGG6 Overview
On this page you'll find an in-depth profile of Ubs (lux) Investment Sicav - China A Opportunity (usd) I-a2-acc Usd. Learn about the key management, total assets, investment strategy and contact information of 0P0001EGG6 among other information.
Investment Strategy
The investment objective of the sub‐fund is to achieve high capital gains and a reasonable return, while giving due consideration to capital security and to the liquidity of assets. The actively managed sub‐fund will invest at least 70% of its total net assets in equities and other equity interests in companies which are domiciled in or are chiefly active in the PRC and/or part of the benchmark MSCI China A Onshore. The majority of net assets are invested in Chinese A‐shares. Chinese A‐shares are Renminbi‐denominated shares of companies domiciled in mainland China (further referred to as "A‐shares"); these A‐shares are traded on Chinese stock exchanges such as the Shanghai Stock Exchange and the Shenzhen Stock Exchange.
Contact Information
Address
5, rue Jean Monnet
Luxembourg,* L-2180
Luxembourg
Luxembourg,* L-2180
Luxembourg
Phone
+352 4 36 16 11
Fax
+352 4 36 16 1555
Top Executives
| Name | Title | Since | Until |
|---|---|---|---|
| Morris Wu | Research Analyst | 2019 | Now |
| Biography | Morris is a member of the Global Emerging Markets and Asia Pacific Equities team and is responsible for investment analysis of China/Hong Kong equities. Morris joined UBS Global Asset Management in May 2015. Prior to this, he was a consulting director at BDA China, providing investment advisory services to top tier hedge funds and private equity funds for their investments in China. Morris worked at BDA for 9 years and specialized in the Consumer and TMT sectors. | ||
| Denise Cheung | - | 2018 | Now |
| Bin Shi | Portfolio Manager | 2013 | Now |
| Biography | Bin Shi is a member of the Global Emerging Market and Asia Pacific Equities team, located in Hong Kong. He is Country Analyst and Portfolio Manager for China with a focus on Chinese stocks listed on both the overseas and domestic Chinese stock exchanges. Prior to joining UBS Asset Management, Bin spent three years as Head of Int’l Business, portfolio manager and analyst with Boshi Fund Management Co., one of the largest domestic mutual fund companies in China. Prior to that, he worked in the US for eight years as portfolio manager and analyst for several US mutual fund firms. Bin joined UBS in January 2006 and has managed the Greater China Fund since April 2006. | ||
| Yu Zhang | - | 2018 | 2019 |
| Derrick Sun | - | 2009 | 2018 |
| Biography | Derrick Sun is a member of the Global Emerging Markets and Asian Pacific Equities team and is responsible for investment analysis of China/Hong Kong Equities. Derrick joined UBS Asset Management in July 2013. Prior to this, he was head of research for healthcare and small & mid-cap with Bank of China International (BOCI) and BNP Paribas. Previous industry experience includes 5 years managing a bio-pharmaceutical company’s Shanghai subsidiary and 5 years in Deloitte Consulting (US) where he provided business consulting services to Fortune 500 healthcare and consumer companies. | ||
| Projit Chatterjee | - | 2007 | 2018 |
| Biography | Projit Chatterjee is a Senior Equity Specialist within the Global Emerging Markets and Asia Pacific Equities team at UBS Asset Management, based in Singapore. He is also a member of the Global Emerging Markets Strategy Committee and co-manager of the GEM High Dividend funds. Projit has primary responsibility for overall product positioning and development of Emerging Markets and Asian Equity strategies, as well as marketing and communication of these strategies to existing and prospective clients globally. Projit joined UBS in 1997 as a Corporate Finance Analyst with UBS Investment Bank in Mumbai, India. In 1999, he moved to UBS Asset Management in Zurich to work in Strategic Projects, International Fund Marketing. In Zurich, Projit held various roles in the areas of strategic business development, business management and investment solutions. He also led an acquisition project in the Indian market. Before joining UBS, Projit worked as a money market and foreign exchange dealer in the treasury of MashreqBank, a UAE bank in Mumbai. | ||
Write your thoughts about Ubs (lux) Investment Sicav - China A Opportunity (usd) I-a2-acc Usd
Are you sure you want to delete this chart?
Delete Cancel
Replace the attached chart with a new chart ?
Replace Cancel
Comment Guidelines
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review